GSK plc American Depositary Shares (Each representing two Ordinary Shares) (GSK)
R&D to Revenue
20.47%
Quarterly · Period ending:
GSK R&D to Revenue
Latest reported20.47%period ending
Latest reported20.47%period ending
GSK Quarterly R&D/Revenue (0.00% → 20.47%)
Latest values, visible window
High-resolution chart · PNG
GSK r&d to revenue history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 12.8075% | |
| 12.5079% | |
| 14.4959% | |
| 14.4276% | |
| 13.6203% | |
| 13.2242% | |
| 0% | |
| 0% | |
| 14.1266% | |
| 0% | |
| 0% | |
| 0% | |
| 14.2817% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% |